A research team at National Sun Yat-sen University has developed a non-invasive imaging technology designed for diagnosing ...

Telix CEO Christian Behrenbruch hinted changes to the US Food and Drug Administration have hampered approval of its new brain ...

Telix (ASX:TLX) has copped a sharp jab on Monday as the FDA says its drug TLX101-CDx, AKA Floretyrosine, can’t be accepted ...

Telix Pharmaceuticals said it received a "disappointing outcome" from the US Food and Drug Administration (FDA), after the ...

Telix has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain cancer diagnostic ...

Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...

Researchers have developed an AI model that analyzes sequences of brain scans to accurately predict tumor recurrence in children with gliomas.

Researchers trained and validated a deep learning model that can detect subtle changes across post-treatment brain scans and forecast glioma recurrence with up to 89 percent accuracy.

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers.